Consumer Health Literacy

Overview

The Quality Use of Diagnostics, Therapeutics and Pathology Program (the Program) is an Australian Government initiative administered by the department. The Program was established in 1999 and provides funding to improve the way medicines and medical tests are prescribed and used.  As part of the 2022-23 Budget Measure: Guaranteeing Medicare and Access to Medicines – Improving Access to Medical Equipment, Treatment and Diagnostics, the Program is being redesigned with two new competitive grant opportunities that will run every two years: Health Professional Education Grant Opportunity (this grant opportunity); and Consumer Health Literacy Grant Opportunity (also currently open for application, via GrantConnect).  The Program contributes to the implementation of Australia’s National Medicines Policy (NMP), and the National Strategy for Quality Use of Medicines (NSQUM) by fostering cross sector collaboration and partnerships, collecting data, providing information, raising awareness and educating health professionals and consumers about the quality use of medicines and diagnostics. Quality Use of Medicines (QUM) objectives must be achieved within a complex and crowded QUM ecosystem. This complexity underscores the need for the Program to be implemented in a manner consistent with the NSQUM’s five principles: primacy of the consumer; partnership, consultative, collaborative, multi-disciplinary activity; support for existing activity; and system-based approaches. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left hand side.